Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

2020 New England Journal of Medicine 1,863 citations

Abstract

Early rhythm-control therapy was associated with a lower risk of adverse cardiovascular outcomes than usual care among patients with early atrial fibrillation and cardiovascular conditions. (Funded by the German Ministry of Education and Research and others; EAST-AFNET 4 ISRCTN number, ISRCTN04708680; ClinicalTrials.gov number, NCT01288352; EudraCT number, 2010-021258-20.).

Keywords

Atrial fibrillationRhythmCardiologyInternal medicineMedicine

Affiliated Institutions

Related Publications

Dexamethasone in Hospitalized Patients with Covid-19

In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxyg...

2020 New England Journal of Medicine 9762 citations

Publication Info

Year
2020
Type
article
Volume
383
Issue
14
Pages
1305-1316
Citations
1863
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1863
OpenAlex

Cite This

Paulus Kirchhof, A. John Camm, Andreas Goette et al. (2020). Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. New England Journal of Medicine , 383 (14) , 1305-1316. https://doi.org/10.1056/nejmoa2019422

Identifiers

DOI
10.1056/nejmoa2019422